BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27823642)

  • 1. ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma.
    Ahmed M; Li L; Pinnix C; Dabaja B; Nomie K; Lam L; Wang M
    Crit Rev Oncol Hematol; 2016 Nov; 107():14-19. PubMed ID: 27823642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
    Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function.
    Menezes DL; Holt J; Tang Y; Feng J; Barsanti P; Pan Y; Ghoddusi M; Zhang W; Thomas G; Holash J; Lees E; Taricani L
    Mol Cancer Res; 2015 Jan; 13(1):120-9. PubMed ID: 25232030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
    Fang NY; Greiner TC; Weisenburger DD; Chan WC; Vose JM; Smith LM; Armitage JO; Mayer RA; Pike BL; Collins FS; Hacia JG
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5372-7. PubMed ID: 12697903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
    Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E
    Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
    Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
    Mareckova A; Malcikova J; Tom N; Pal K; Radova L; Salek D; Janikova A; Moulis M; Smardova J; Kren L; Mayer J; Trbusek M
    Leuk Lymphoma; 2019 Jun; 60(6):1420-1428. PubMed ID: 30626249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.
    M'kacher R; Bennaceur A; Farace F; Laugé A; Plassa LF; Wittmer E; Dossou J; Violot D; Deutsch E; Bourhis J; Stoppa-Lyonnet D; Ribrag V; Carde P; Parmentier C; Bernheim A; Turhan AG
    Oncogene; 2003 Sep; 22(39):7905-12. PubMed ID: 12970738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood complete remission after splenic irradiation in mantle-cell lymphoma with 11q22-23 deletion and ATM inactivation.
    Filippi AR; Franco P; Galliano M; Ricardi U
    Radiat Oncol; 2006 Sep; 1():35. PubMed ID: 16956411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM mutations in sporadic lymphoid tumours.
    Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
    Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma.
    Sarkar A; Stellrecht CM; Vangapandu HV; Ayres M; Kaipparettu BA; Park JH; Balakrishnan K; Burks JK; Pandita TK; Hittelman WN; Neelapu SS; Gandhi V
    Haematologica; 2021 Feb; 106(2):495-512. PubMed ID: 32029507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ATM gene in the pathogenesis of mantle-cell lymphoma.
    Stilgenbauer S; Schaffner C; Winkler D; Ott G; Leupolt E; Bentz M; Möller P; Müller-Hermelink HK; James MR; Lichter P; Döhner H
    Ann Oncol; 2000; 11 Suppl 1():127-30. PubMed ID: 10707794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial lymphoid neoplasms in patients with mantle cell lymphoma.
    Tort F; Camacho E; Bosch F; Harris NL; Montserrat E; Campo E
    Haematologica; 2004 Mar; 89(3):314-9. PubMed ID: 15020270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma.
    Stilgenbauer S; Winkler D; Ott G; Schaffner C; Leupolt E; Bentz M; Möller P; Müller-Hermelink HK; James MR; Lichter P; Döhner H
    Blood; 1999 Nov; 94(9):3262-4. PubMed ID: 10556216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SKP2 Activity Impaired ATM-Mediated DNA Repair and Enhanced Sensitivity of Cisplatin-Resistant Mantle Cell Lymphoma Cells.
    Yan W; Yang Y; Yang W
    Cancer Biother Radiopharm; 2019 Sep; 34(7):451-458. PubMed ID: 31025879
    [No Abstract]   [Full Text] [Related]  

  • 16. NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines.
    Verner J; Trbusek M; Chovancova J; Jaskova Z; Moulis M; Folber F; Halouzka R; Mayer J; Pospisilova S; Doubek M
    Leuk Lymphoma; 2015; 56(11):3198-206. PubMed ID: 25827173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
    Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
    Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
    Zhang J; Jima D; Moffitt AB; Liu Q; Czader M; Hsi ED; Fedoriw Y; Dunphy CH; Richards KL; Gill JI; Sun Z; Love C; Scotland P; Lock E; Levy S; Hsu DS; Dunson D; Dave SS
    Blood; 2014 May; 123(19):2988-96. PubMed ID: 24682267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.
    Beà S; Valdés-Mas R; Navarro A; Salaverria I; Martín-Garcia D; Jares P; Giné E; Pinyol M; Royo C; Nadeu F; Conde L; Juan M; Clot G; Vizán P; Di Croce L; Puente DA; López-Guerra M; Moros A; Roue G; Aymerich M; Villamor N; Colomo L; Martínez A; Valera A; Martín-Subero JI; Amador V; Hernández L; Rozman M; Enjuanes A; Forcada P; Muntañola A; Hartmann EM; Calasanz MJ; Rosenwald A; Ott G; Hernández-Rivas JM; Klapper W; Siebert R; Wiestner A; Wilson WH; Colomer D; López-Guillermo A; López-Otín C; Puente XS; Campo E
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18250-5. PubMed ID: 24145436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.
    Pitter KL; Casey DL; Lu YC; Hannum M; Zhang Z; Song X; Pecorari I; McMillan B; Ma J; Samstein RM; Pei IX; Khan AJ; Braunstein LZ; Morris LGT; Barker CA; Rimner A; Alektiar KM; Romesser PB; Crane CH; Yahalom J; Zelefsky MJ; Scher HI; Bernstein JL; Mandelker DL; Weigelt B; Reis-Filho JS; Lee NY; Powell SN; Chan TA; Riaz N; Setton J
    J Natl Cancer Inst; 2021 Mar; 113(3):266-273. PubMed ID: 32726432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.